AzTrials
AzTrials

LearningNCT07706998

Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis

A study testing An iLN interactive teaching platform and PPT in people with Learning, run by Nanjing University at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Aim: To evaluate the application effect of the teaching platform iLN in the teaching of lupus nephritis, aiming to provide practical experience and evidence-based support for the implementation of generative AI technology in professional medical education. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Learning
What is being tested?
An iLN interactive teaching platform and PPT
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteChina
Study dates
1 Jul 2026to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • As a student majoring in clinical medicine
  • Volunteering to participate in the study

Who cannot join

  • Inability to understand, read, or communicate in Chinese
  • Failure to participate in any stage of the study (e.g. in-class education session, or post-test)
  • Requesting withdrawal from the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hao Bao, Doctor. contact

86-15062213937

bhao@nju.edu.cn

China1 site
  • Nanjing university

    Nanjing, Jiangsu, 210016

Other trials in China

About this study

Aim:

To evaluate the application effect of the teaching platform iLN in the teaching of lupus nephritis, aiming to provide practical experience and evidence-based support for the implementation of generative AI technology in professional medical education.

Read more

Method:

Based on the DeepSeek large language model, the investigators developed "iLN" - an interactive teaching platform for lupus nephritis. This platform integrates the latest authoritative textbooks, clinical guidelines, pathological atlases, and real clinical cases, and includes seven core modules, such as "case interaction", "knowledge teaching", and "AI question answering". The investigators conducted a randomized controlled trial (RCT) on 50 fourth-year undergraduate students from Nanjing University School of Medicine to evaluate the effectiveness of the iLN platform compared to traditional teaching methods. The teaching effect was evaluated through objective test scores and questionnaires about student satisfaction and platform usability.

Read the detailed description

Artificial Intelligence (AI) technology is reshaping the landscape of medical education with unprecedented depth and breadth. From early rule-based teaching expert systems to the current generation of Generative AI (GAI) systems like ChatGPT and DeepSeek, the continuous evolution of technology has not only greatly enriched teaching methods but also fundamentally changed the ways knowledge is acquired, disseminated, and evaluated. Internationally, Generative AI (GAI) has been widely applied in creating virtual cases, constructing clinical simulation scenarios, assisting medical writing, and providing personalized learning plans for medical students. However, there are almost no dedicated large language model (GAI) teaching applications specifically for lupus nephritis (LN) worldwide. As the most common severe organ complication of systemic lupus erythematosus (SLE), LN affects approximately 50% to 70% of SLE patients with kidney involvement. Its diagnosis and treatment involve multiple complex processes, including the identification of clinical manifestations, the interpretation of immune markers, the assessment of renal pathological types, the quantification of disease activity, and the formulation of personalized treatment plans. All of these place extremely high demands on the knowledge integration and clinical reasoning skills of medical students. The traditional LN teaching model mainly relies on theoretical classroom lectures and is supplemented by static pathological image presentations. Some scholars have introduced problem-based learning (PBL) teaching models and integrated ideological and political education, but there are still significant deficiencies: (1) Knowledge update lag - In the field of LN, new diagnostic standards (such as the 2019 EULAR/ACR systemic lupus erythematosus classification criteria), new pathological classifications (such as the 2018 ISN/RPS revised version), and new drug treatment regimens (such as belimumab) are constantly emerging, while the textbook revision cycle is relatively long, making it difficult for students to obtain the latest knowledge in a timely manner; (2) Lack of personalized teaching - Facing students with varying levels of basic knowledge, teachers find it difficult to meet the needs of different learning paces; students with weak foundations have difficulty understanding complex pathological mechanisms, while those with solid foundations may find the content too simplistic; (3) Insufficient clinical reasoning training - Traditional classrooms lack real clinical scenario simulations, and students listen passively rather than actively exploring, making it difficult for them to establish a complete clinical reasoning chain from "symptoms - signs - laboratory tests - pathology - diagnosis - treatment". In this context, building a GAI-assisted teaching platform specifically designed for LN teaching, fully leveraging the personalized interaction, dynamic content generation, and intelligent assessment capabilities of AI, is of great significance for teaching reform and innovation.

In this study, the investigators constructed an iLN interactive teaching platform for lupus nephritis based on the DeepSeek large language model and by integrating the latest authoritative textbooks, guidelines, and clinical pathology materials. Through a randomized controlled teaching trial, the investigators systematically evaluated the application effect of this platform in LN teaching, aiming to provide practical experience and evidence-based support for the implementation of GAI technology in specialized medical education.

Conditions
Learning
Being tested
An iLN interactive teaching platform, PPT
Keywords
Generative artificial intelligence, DeepSeek, Lupus nephritis, Medical education
Medical subject headings
Lupus Nephritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • An iLN interactive teaching platformDevice

    An iLN interactive teaching platform for lupus nephritis based on the DeepSeek large language model and by integrating the latest authoritative textbooks, guidelines, and clinical pathology materials.

  • PPTOther

    Adopted the traditional PowerPoint (PPT) lecture mode. The instructor used uniformly prepared PPT courseware to sequentially lecture on the SLE overview, LN clinical manifestations, laboratory tests, pathological classification, diagnostic criteria, treatment plans, and prognosis evaluation. The courseware included static pathological and clinical manifestation images.

Study groups in NCT07706998
Study groupRoleWhat they receive
GAI-assisted teaching groupExperimentalGAI-assisted teaching group: Students used various platform modules for self-directed learning under the instructor's guidance: (1) In the "Case Interaction" module, students interacted with three virtual cases by inputting natural language questions (e.g., "Does the patient have edema?", "What is the patient's proteinuria level?", "What are the light microscopy results of the renal biopsy?"). The platform automatically determines the question type and provides the corresponding information, while the visualized patient model on the right side simultaneously highlights the affected systems already identified, and the case information acquisition progress bar is updated dynamically; (2) When students encounter difficulties, they can invoke DeepSeek in real time for immediate answers through the "AI Q\&A" module; (3) After completing case interactions, students proactively summarized the history characteristics, with the instructor providing supplementary input; (4) The instructor guided
Receives: Device: An iLN interactive teaching platform
Traditional teaching groupOtherTraditional teaching group: Adopted the traditional PowerPoint (PPT) lecture mode. The instructor used uniformly prepared PPT courseware to sequentially lecture on the SLE overview, LN clinical manifestations, laboratory tests, pathological classification, diagnostic criteria, treatment plans, and prognosis evaluation. The courseware included static pathological and clinical manifestation images.
Receives: Other: PPT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Objective Test Scores

    Unified in-class objective test (20 multiple-choice questions, 5 points each, 100 points total),the higher the score, the better the performance.

    Measured: On the day of the end of the teaching session within 30 minutes after teaching session

Secondary outcomes (1)
  1. Questionnaire Survey

    Students in the GAI group filled out the questionnaire on the iLN platform, including overall satisfaction (satisfied/dissatisfied), and gave scores (from 1 to 5) on 12 dimensions such as the platform's interest, teaching novelty, content clarity, interface design, and learning effect improvement. They also submitted open-ended suggestions for improvement.

    Measured: On the day of the end of the teaching session within 60 minutes after teaching session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2026
  2. Study start1 Jul 2026 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07706998
Sponsor's protocol ID
NDY2025004
Status last verified
Jul 2026
First submitted
30 Jun 2026
Last updated
16 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared

Publications

  • Lin Y, Luo Z, Ye Z, Zhong N, Zhao L, Zhang L, Li X, Chen Z, Chen Y. Applications, Challenges, and Prospects of Generative Artificial Intelligence Empowering Medical Education: Scoping Review. JMIR Med Educ. 2025 Oct 23;11:e71125. doi: 10.2196/71125.

    PubMed 41128430

Questions about this trial

What is this clinical trial studying?

A study testing An iLN interactive teaching platform and PPT in people with Learning, run by Nanjing University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hao Bao, Doctor. (86-15062213937, bhao@nju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Objective Test Scores (time frame: On the day of the end of the teaching session within 30 minutes after teaching session). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07706998, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in